A novel anti-inflammatory drug targeting purinergic receptors
| Project/Area Number |
22790088
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Tokyo University of Science |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | 免疫学 / 薬学 / プリン受容体 / ATP / 炎症 / T細胞 / マクロファージ / 免疫 / P2X受容体 / P2Y受容体 / ATP受容体 |
|---|
| Research Abstract |
It is important to establish a novel target of anti-inflammatory drug because immune disease is increasing in all over the world. In this study, I found that P2X7 and P2Y6 purinergic receptors play an important role in activation of T cells and macrophages. The antagonists of these receptors significantly suppressed the increase of pro-inflammatory cytokine levels in sepsis model. I propose that the antagonists of P2X7 and P2Y6 receptors would be candidates of novel anti-inflamatory drug.
|
Report
(3 results)
Research Products
(16 results)
